Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2010
09/16/2010US20100233153 Novel gene disruptions, compositions and the methods relating thereto
09/16/2010US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof
09/16/2010CA2755120A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010CA2754801A1 Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as dhodh inhibitor
09/16/2010CA2754785A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
09/16/2010CA2754613A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010CA2754589A1 Steroid compound
09/15/2010EP2228435A1 Method for amplification of hematopoietic stem cell using heterocyclic compound
09/15/2010EP2228434A1 Amplification method for hematopoietic stem cells with heterocyclic compound
09/15/2010EP2228389A2 Antibodies against vascular endothelial growth factor 2
09/15/2010EP2228378A1 Monosebacate of pyrazole derivative
09/15/2010EP2228060A1 Oral dosage forms comprising fenofibrate
09/15/2010EP2227256A1 Method for treating bone fracture with anti-sclerostin antibodies
09/15/2010EP2227242A2 Bone morphogenic protein binding peptide
09/15/2010EP1536837B1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
09/15/2010EP1501819B1 Estrogen receptor modulators
09/15/2010EP1250055B1 Immune modulation with death receptor-induced apoptosis
09/15/2010CN1736466B Use of straw extract
09/15/2010CN101835787A C2-C5-alkyl-imidazole-bisphosphonates
09/15/2010CN101835770A Condensed compounds with activity at estrogen receptors
09/15/2010CN101835501A Composition for treatment of joint disease
09/15/2010CN101831435A Preparation and application of IL-15 isoform protein of mice
09/15/2010CN101831004A Hyaluronic acid strontium salt compounds, preparation method thereof and application in medicine
09/15/2010CN101830889A 嘧啶衍生物 Pyrimidine derivatives
09/15/2010CN101830835A Sodium paeonol sulfonate crystalline hydrate as well as preparation method and application thereof
09/15/2010CN101829313A Footbath effervescent tablet for improving rheumatic arthritis
09/15/2010CN101829312A Medicament for treating rheumatoid arthritis and preparation method thereof
09/15/2010CN101829311A Medicament for treating gonarthromeningitis and preparation method thereof
09/15/2010CN101829291A Traditional Chinese medicine preparation for treating rheumatism and preparation method thereof
09/15/2010CN101829283A Traditional Chinese medicine for treating lung cancer, gastric cancer, bone marrow cancer and metrocarcinoma and preparation method thereof
09/15/2010CN101829265A Medicine composition for treating arthritis and gout, preparation method and preparation and application thereof
09/15/2010CN101829264A Medicine composition for treating hyperuricemia and related diseases and preparation method and application thereof
09/15/2010CN101829249A Traditional Chinese medicine powder for treating rheumatoid diseases
09/15/2010CN101829224A Traditional Chinese medicine composition preparation and preparation method and quality control method
09/15/2010CN101829215A External-use powder for treating burns, scalds and wound infections
09/15/2010CN101829202A Traditional Chinese medicine composition for treating cervical vertebra pain and other diseases caused by cervical spondylosis
09/15/2010CN101829174A Application of erigeron breviscapus extract in preparing anti-tumor or angiogenesis-suppressing medicaments, health-care food or cosmetics
09/15/2010CN101829163A Application of rhizoma nardostachyos in preparing medicine for preventing and treating osteoporosis
09/15/2010CN101829143A Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
09/15/2010CN101829125A Compound combined formulation for preventing and treating osteoarthrosis and preparation method thereof
09/15/2010CN101829108A Application of diterpene ginkgolide
09/15/2010CN101828771A Calcium carbide liquid health-care clothes
09/15/2010CN101828720A Health food for reinforcing bone mineral density
09/15/2010CN101371823B Technique for preparing double-acetyl emodic acid sustained-release capsules
09/15/2010CN101361828B Medicine for treating scapulohumeral periarthritis and preparation method thereof
09/15/2010CN101297853B Bone-melon extract injection and preparation thereof
09/15/2010CN101269157B Method for preparing wine for warming meridian, removing paralysism, releasing tendon, activating collaterals to relieve pain
09/15/2010CN101264160B Bone-setting and pain-relieving Chinese medicine composition and preparation thereof
09/15/2010CN101181622B Method for preparing water extraction of white vein ointment
09/15/2010CN101181355B Medicament for curing rheumatism and rheumatoid as well as preparation method thereof
09/15/2010CN101156903B A externally used traditional Chinese medicine preparation for treating scapulohumeral periarthritis as well as its preparation method
09/14/2010USRE41676 Intelligent serial battery charger and charging block
09/14/2010US7795494 Transgenic animals capable of generating antibodies, e.g., human monoclonal antibodies, specific for the product of a gene of interest
09/14/2010US7795428 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
09/14/2010US7795214 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases
09/14/2010US7795023 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
09/14/2010US7795018 expresses CD14, CD34, CD45, type I collagen, and HLA-DR; differentiates into osteoblasts, skeletal myoblasts or chondrocytes; obtained by culturing peripheral blood mononuclear cells (PBMCs) in vitro on fibronectin; noninvasive; will not cause rejection at the time of cell transplantation
09/14/2010US7794744 Nutritional modules
09/14/2010US7794715 T-cell immune response cDNA 7 (TIRC7) antagonist; rheumatoid arthritis; comprising all three complementarity determining regions (CDRs) of the VH and all three complementarity determining regions (CDRs) of the VL variable regions
09/14/2010CA2441501C Rho-kinase inhibitors
09/14/2010CA2434834C 6-substituted pyrido-pyrimidines
09/14/2010CA2432009C Pharmaceutical preparations comprising a salt of an antibiotic and an antiphlogistic and use thereof
09/14/2010CA2388342C Composition for restoring defects in calcified tissues
09/14/2010CA2322792C Polypeptides homologous to vegf and bmp1
09/14/2010CA2320202C Agents and methods for protection, treatment and repair of connective tissue
09/14/2010CA2222217C Use of fibroblast growth factors mutants to stimulate bone growth
09/10/2010WO2010101537A1 Pharmaceutical composition of alendronate and a calcium salt combined in a single dosage form
09/10/2010WO2010101192A1 Prophylactic or therapeutic agent for rheumatoid arthritis or rheumatoid arthritis-related diseases
09/10/2010WO2010101164A1 Pyridine derivative
09/10/2010WO2010100431A1 Pyrrolopyrimidines used as kinase inhibitors
09/10/2010WO2010100070A1 Inhibitors of bruton's tyrosine kinase
09/10/2010WO2010050783A3 Novel compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same
09/10/2010CA2754446A1 Pyridine derivative
09/10/2010CA2753341A1 Inhibitors of bruton's tyrosine kinase
09/10/2010CA2753236A1 Pyrrolopyrimidines used as kinase inhibitors
09/09/2010US20100228018 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/09/2010US20100227889 Benzimidazole Derivatives
09/09/2010US20100227860 Disalt inhibitors of il-12 production
09/09/2010US20100227859 Tricyclic compounds as matrix metalloproteinase inhibitors
09/09/2010US20100227856 Novel compounds
09/09/2010US20100227855 Helix 12 directed non-steroidal antiandrogens
09/09/2010US20100227853 Inhibitors of cyclic amp phosphodiesterases
09/09/2010US20100227845 Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
09/09/2010US20100227830 Use of escin
09/09/2010US20100227824 Pharmaceutical peptides for the treatment of inflammatory diseases
09/09/2010US20100227815 Site-specific pegylated linear salmon calcitonin analogues
09/09/2010US20100227807 Use of Gelsolin to Diagnose and Treat Inflammatory Desease (Stossel)
09/09/2010US20100227805 Molecules and Methods of Using Same for Treating CCR5/CCR5 Ligands Associated Diseases
09/09/2010US20100227804 Gel-forming composition for medical use, administration device for the composition, and drug release controlling carrier
09/09/2010US20100227800 Triazole derivatives as kinase inhibitors
09/09/2010US20100227354 Autoimmune Conditions and NADPH Oxidase Defects
09/09/2010US20100227006 Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
09/09/2010US20100226996 Compositions and methods of delivery of pharmacological agents
09/09/2010US20100226993 Composition for regenerative treatment of cartilage disease
09/09/2010US20100226977 Low viscosity phospholipid compositions
09/09/2010US20100226961 Cross-linked bioactive hydrogel matrices
09/09/2010US20100226956 Production of moldable bone substitute
09/09/2010US20100226928 Lyophilised Antibody Formulation
09/09/2010US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides
09/09/2010US20100226894 Mobilization of a complete cells mixture with embryonic like stem cells from the peripheral blood